The Jakarta Post
Kimia Farma Sungwun Pharmacopia (KFSP) has started the construction of its first pharmaceutical raw materials factory in Cikarang, West Java, to reduce the country’s dependency on imports of such materials from China and India.
KFSP, a joint venture between state-owned pharmaceutical giant Kimia Farma and South Korea-based Sungwun Pharmacopia, will produce eight types of active pharmaceutical ingredients (API) for medicine after the factory completes its first development stage.
By then, it will be able to produce 30 tons of the eight types of API per year and 23 tons of the production will be exported to several countries, including Japan and the US.
The factory, which is expected to begin operations in 2018, will also produce seven types of high function chemicals per year to be used as raw materials for cosmetics and food supplements. It will have an annual cap...